APA (7th ed.) Citation

Dogan Turacli, I., Cingir Koker, S., Paspal Eroglu, K., & Yalcin, B. (2026). Targeting Activated Pathways in Doxorubicin-Resistant TNBC Alters Signaling, Survival and EMT: A Double-Edged Sword. International Journal of Molecular Sciences, 27(6), 2792. https://doi.org/10.3390/ijms27062792

Chicago Style (17th ed.) Citation

Dogan Turacli, Irem, Sahika Cingir Koker, Kubra Paspal Eroglu, and Banu Yalcin. "Targeting Activated Pathways in Doxorubicin-Resistant TNBC Alters Signaling, Survival and EMT: A Double-Edged Sword." International Journal of Molecular Sciences 27, no. 6 (2026): 2792. https://doi.org/10.3390/ijms27062792.

MLA (9th ed.) Citation

Dogan Turacli, Irem, et al. "Targeting Activated Pathways in Doxorubicin-Resistant TNBC Alters Signaling, Survival and EMT: A Double-Edged Sword." International Journal of Molecular Sciences, vol. 27, no. 6, 2026, p. 2792, https://doi.org/10.3390/ijms27062792.